Evaluation of two type corticosteroids in Treatment of Oral Lichen Planus
Phase 2
- Conditions
- ichen planus.Diseases of the skin and subcutaneous tissue
- Registration Number
- IRCT201101245678N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
Criteria for inclusion: All patients had symptomatic bilateral erosive or ulcerative oral lichen planus with similar intensity, Not used any systemic or topical corticosteroid, Written informed consent was obtained
Criteria for exclusion: Patients that were not cooperative , use of another topical or systemic during the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Scaling of lesion. Timepoint: 3-6-12 weeks. Method of measurement: REU.;Pain. Timepoint: 3-6-12 weeks. Method of measurement: VAS (Visual Analuge Scaling).;Raughness. Timepoint: 3-6-12 weeks. Method of measurement: VAS.;Maximum diameter of lesion. Timepoint: 3-6-12 weeks. Method of measurement: periodental prob( millimeter).
- Secondary Outcome Measures
Name Time Method Candidiasis, Mucosal atrophy. Timepoint: 3-6-12 weeks. Method of measurement: Clinical evaluation.